That is very important, because the method a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be effective. Simply put, we have to understand how these proteins fold if we desire a drug to work. Historically, this has actually been an experimental process (brownstone research). And now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much simpler to produce drugs that do what they're designed to do. This was an advancement nearly no one saw. But it's going to have extensive ramifications for curing illness. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be a lot of investment opportunities in this space, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (future report review). That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be amazed if it pulled back maybe considerably before going higher - social media. I have actually been covering bitcoin for a long time now. One of the very first research reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I entitled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were mostly educating readers. But that's not the huge question anymore. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a huge factor I'm bullish on it this year. jeff brown market predictions. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are a lot of fantastic private business on the edge of striking the public markets And I've been working on a new method for you to invest even prior to these companies go public.
This opportunity has been constructing over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the information. Go right here to schedule your spot for free.
Emma Walsh here, handling editor of the Diary. Routine Diary readers understand that tech isn't our typical beat (second wave). And when it comes to tech investing, we leave it to the experts. The good news is, we have a number of such specialists in our Rolodex. Our coworker Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing experts we know (tech stocks). In reality, he had several triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge photo and predict what's just around the corner.
That includes things like 5G networks, biotech, expert system, and a lot more. These trends are experiencing exponential development and producing incredible chances for investors. I wish to make certain all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. last year. But in spite of what lots of readers may think, this is a trend that's just starting. Despite the fact that the COVID-19 pandemic interfered with supply chains in 2015, an excellent 250 million 5G-enabled devices were still sold.
And all of this eventually caused Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (first lady). Losing two months of manufacturing and sales actually affects the number of 5G gadgets are offered in the fiscal year. When you think about all of that, selling 250 million units is amazing. More importantly, the delays brought on by the pandemic created a lots of suppressed demand. And that demand is now going to be pressed into 2021. In reality, I predict that more than 500 million 5G devices will be delivered in 2021 - jeff brown top stock pick 2021. Which's not my only 5G forecast When I've talked about 5G in the past, I've described its three various phases.
In Stage Two, 5G devices go on sale. 5G phones and other products start to reach consumers. And in Stage Three, 5G services begin to be offered (jeff brown genome sequencing). That's when we start to see applications working on 5G networks. Consider things like huge multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will begin Phase Three by this summer season. This begins something of a virtuous cycle: Many people don't truly care about the technology. However they will care if there are interesting applications that can only be accessed with a 5G phone.
That leads to more 5G apps being established. In fact, 5G is going to open a suite of amazing applications: self-driving vehicles, the Internet of Things, robotic surgical treatment, and more. All of these innovations need 5G. The financial investment chances moving forward will be enormous. Stepping away from 5G, the next crucial technology I visualize in 2021 is CRISPR genetic editing. CRISPR means "clustered routinely interspaced short palindromic repeat." It's a mouthful. But it is among the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software application.
The program can crash or not function correctly. CRISPR uses a comparable idea but with our genetic code. "Typos" in our genome can lead to illness. CRISPR can correct these "typos." For several years, CRISPR was mostly a specific niche innovation that wasn't well comprehended. And throughout that time, there were really only 3 companies running in this space. However things are altering. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're treating diseases and seeing that this innovation simply works. And as an outcome, a "2nd crop" of early-stage CRISPR business is going public and delivering unbelievable returns. This entire market is efficiently a greenfield opportunity.
There's space for many companies to exist in this area. genetic sequencing companies jeff brown. And there will be more. That's my forecast for CRISPR in 2021. I predict that two or three more hereditary editing companies will hold their IPOs. Sticking to biotechnology, we are seeing incredible things occurring at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software can accurately forecast the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That is necessary since the method a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be reliable.
Historically, this has actually been a trial-and-error process. Today, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're developed to do. And here's my next prediction. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one but several drug therapies produced utilizing this innovation. This was one of those developments that practically no one discovered. However it's going to have profound implications for treating illness. And, obviously, there will be plenty of financial investment chances in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it drew back perhaps significantly before going greater. I've been covering bitcoin for a long period of time now. One of the very first research study reports I ever published was on bitcoin - social media. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anybody who followed my suggestion. But at the time of that initial suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
But no one is asking that concern any longer. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. jeff bezos. Mass, Mutual is a 150-year-old institution. So consider that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more benefit forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and declares the details depends on date since February 2021, however we could not separately validate this claim. Provided Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down a precise figure at this moment. Brown is best understood for his sage-like ability to select winning innovation stocks. He spent more than 25 years investigating innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience offers him an outstanding viewpoint on the market. He's constantly on the hunt for new chances, and he shares a lot of his finest choices in the Near Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an excellent reputation as a stock-picker, and he successfully predicted a few of the greatest financial events of the past 20 years. Although he does not appear to launch his choices to the general public, the service's success is a direct sign of Brown's stock-picking expertise. No one on Wall Street gets it right whenever, but Jeff Brown's accurate predictions have actually made him legions of dedicated fans. That states a lot about his capability. The Near Future Report is released by Brownstone Research study, a popular financial research study publisher. Brownstone Research study provides several research services with a wide array of specializations - diplomatic relations.
The company is also connected with Bonner & Partners, another well-respected research study publisher - jeff brown biotech pick. On its site, Brownstone states its mission is to provide retail investors with professional-grade research: "For too long, the best financial investment research has not been offered to specific financiers. It has been normally reserved for financial investment banks, hedge funds, personal equity, and high-net-worth clients. last week. The objective of Brownstone Research study is to make that type of proprietary research readily available to any financiers looking to gain an edge in the markets. The objective is simple to deliver unique and successful investment research study found no place else." -Brownstone Research study website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also serves as the company's Chief Financial investment Expert.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to provide its clients. After decades of consistent success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a family name throughout most of America. If you understand even a bit about the marketplace, you know that he has a reputation as a King Midas of sorts. genetic sequencing companies jeff brown. Whatever he touches relies on gold! Jeff is well aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big job.
In truth, Brown believes S.A.V. jeff bezos. could be "the biggest pattern of the 2020s, and he's not alone. Inspect out these quotes from other popular S.A.V. bulls: Elon's next big act will be marrying two advanced technologies: expert system and electric automobiles. Musk hopes the mix will assist him develop the very first fully-autonomous, self-driving vehicles ever. It's nothing short of the automobile market's Holy Grail. As you know, electrical lorries and self-driving vehicle stocks have been huge this year, but the Wall Street machine has approved buzz without much concrete outcome. Regardless of a drastic boost in competition over the previous couple of years, Brown still thinks Musk has the best possibility of putting everything together.
tech could be the magic string that connects everything together. S.A.V. means Shared Autonomous Car, and it might be the future of transport. Generally, this technology would permit you to lease your vehicle as a self-governing, self-driving taxi when you're not utilizing it. You just get out of the car and press a button on an app that tells the automobile to "join the fleet." Next thing you understand, you're relaxing on your couch while your cars and truck shuttles ride-sharers around town. Most importantly, you get to keep a significant chunk of the revenues. It sounds ridiculous, however it could be closed than you believe.